Skip to main content

Table 4 Results of this analysis

From: Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials

Outcomes OR with 95% CI P value I2 (%) Statistical model used
ST 0.65 [0.38–1.10] 0.11 6 Fixed effects
Definite ST 1.18 [0.38–3.69] 0.77 3 Fixed effects
Probable ST 0.75 [0.17–3.35] 0.70 0 Fixed effects
Acute ST 0.48 [0.13–1.74] 0.27 0 Fixed effects
Sub-acute ST 0.56 [0.22–1.40] 0.21 0 Fixed effects
Late ST 0.72 [0.23–2.28] 0.58 0 Fixed effects
  1. Abbreviations: OR: Odds ratios, CI: Confidence intervals, ST: Stent thrombosis, RCT: Randomized controlled trials, OS: Observational studies